NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.
about
NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?NK cell destiny after haploSCT with PT-Cy.Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation.Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.
P2860
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
NK cell recovery after haploid ...... ics and clinical implications.
@en
NK cell recovery after haploid ...... ics and clinical implications.
@nl
type
label
NK cell recovery after haploid ...... ics and clinical implications.
@en
NK cell recovery after haploid ...... ics and clinical implications.
@nl
prefLabel
NK cell recovery after haploid ...... ics and clinical implications.
@en
NK cell recovery after haploid ...... ics and clinical implications.
@nl
P2093
P2860
P50
P1433
P1476
NK cell recovery after haploid ...... mics and clinical implications
@en
P2093
Andrea Assanelli
Antonio Russo
Fabio Ciceri
Fabio Giglio
Francesca Lorentino
Giacomo Oliveira
Laura Zito
Leo Luznik
Mara Morelli
Maria Teresa Lupo Stanghellini
P2860
P304
P356
10.1182/BLOOD-2017-05-780668
P407
P577
2017-10-06T00:00:00Z